Furthermore, the correlation between the pre-treatment expression levels of TNIP1 and its transcription factors with the degree of depression improvement indicated that lower pre-treatment levels of PPAR-γ were associated with better therapeutic outcomes in alleviating depression. The gene discussed is TNIP1; the disease is major depressive disorder.